PMID: 6162995Dec 1, 1980Paper

Antiarrhythmic effect and influence on myocardial contractile function of the preparation, mexitil

Kardiologiia
L I Ol'binskaiaV A Sandrikov

Abstract

Complex clinical instrumental examination of 30 patients with disorders of cardiac rhythm and experimental study on 49 albino rats with induced transitory coronary insufficiency of various duration which were then subjected to reperfusion showed that Mexitil is an effective anti-arrhythmic agent in the treatment of ventricular disorders of rhythm and that during long-term treatment wih it inotropic myocardial function diminishes insignificantly; treatment produced positive results in 73% of patients.

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.